仁和药业(000650)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

000650 仁和药业

已收盘 05-06 15:00:00

{"stockData":{"symbol":"000650","market":"SZ","secType":"STK","nameCN":"仁和药业","latestPrice":6.78,"timestamp":1714979031000,"preClose":6.53,"halted":0,"volume":39493840,"delay":0,"floatShares":1331000000,"shares":1400000000,"eps":0.4017,"marketStatus":"已收盘","marketStatusCode":5,"change":0.25,"latestTime":"05-06 15:00:00","open":6.62,"high":6.78,"low":6.61,"amount":266000000,"amplitude":0.026,"askPrice":6.79,"askSize":6183,"bidPrice":6.78,"bidSize":2192,"shortable":0,"etf":0,"ttmEps":0.4017,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1715045400000},"adr":0,"adjPreClose":6.53,"symbolType":"stock","openAndCloseTimeList":[[1714959000000,1714966200000],[1714971600000,1714978800000]],"highLimit":7.18,"lowLimit":5.88,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":1399938234,"pbRate":1.49,"roa":"--","roe":"2.92%","epsLYR":0.41,"committee":-0.490202,"marketValue":9492000000,"floatMarketCap":9027000000,"peRate":16.878268,"changeRate":0.0383,"turnoverRate":0.0297,"status":0},"requestUrl":"/m/hq/s/000650/","defaultTab":"news","newsList":[{"id":"2431801036","title":"仁和药业（000650）4月29日主力资金净买入2178.22万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2431801036","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2431801036?lang=zh_cn&edition=full","pubTime":"2024-04-30 09:22","pubTimestamp":1714440170,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年4月29日收盘，仁和药业报收于6.52元，下跌0.46%，换手率3.97%，成交量52.89万手，成交额3.44亿元。近5日资金流向一览见下表：仁和药业融资融券信息显示，融资方面，当日融资买入2726.65万元，融资偿还1440.82万元，融资净买入1285.83万元。仁和药业主营业务：生产、销售中西药、原料药及健康相关产品。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024043000018487.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2431882446","title":"图解仁和药业一季报：第一季度单季净利润同比减2.74%","url":"https://stock-news.laohu8.com/highlight/detail?id=2431882446","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2431882446?lang=zh_cn&edition=full","pubTime":"2024-04-29 17:39","pubTimestamp":1714383571,"startTime":"0","endTime":"0","summary":"证券之星消息，仁和药业2024年一季报显示，公司主营收入12.38亿元，同比下降8.72%；归母净利润1.77亿元，同比下降2.74%；扣非净利润1.01亿元，同比下降42.28%；负债率11.89%，投资收益693.43万元，财务费用-677.05万元，毛利率36.66%。财报数据概要请见下图: 以上内容由证券之星根据公开信息整理，由算法生成（网信算备310104345710301240019号），与本站立场无关，如数据存在问题请联系我们。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042900022842.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2431857886","title":"仁和药业最新公告：一季度归母净利润1.77亿元 同比下降2.74%","url":"https://stock-news.laohu8.com/highlight/detail?id=2431857886","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2431857886?lang=zh_cn&edition=full","pubTime":"2024-04-29 16:56","pubTimestamp":1714380970,"startTime":"0","endTime":"0","summary":"仁和药业发布2024年一季度报告，第一季度归母净利润1.77亿元，同比下降2.74%。以上内容由证券之星根据公开信息整理，由算法生成（网信算备310104345710301240019号），与本站立场无关，如数据存在问题请联系我们。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042900018807.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2431988642","title":"仁和药业：一季度净利润1.77亿元，同比下降2.74%","url":"https://stock-news.laohu8.com/highlight/detail?id=2431988642","media":"澎湃新闻","top":-1,"share":"https://www.laohu8.com/m/news/2431988642?lang=zh_cn&edition=full","pubTime":"2024-04-29 16:54","pubTimestamp":1714380840,"startTime":"0","endTime":"0","summary":"4月29日，仁和药业股份有限公司（仁和药业，000650）披露一季报，一季度实现营业收入12.38亿元，同比下降8.72%；净利润1.77亿元，同比下降2.74%；基本每股收益0.13元。\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/jjxw/2024-04-29/doc-inatnyix1244999.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2024-04-29/doc-inatnyix1244999.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2431007587","title":"仁和药业(000650.SZ)发布一季度业绩，净利润1.77亿元，下降2.74%","url":"https://stock-news.laohu8.com/highlight/detail?id=2431007587","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2431007587?lang=zh_cn&edition=full","pubTime":"2024-04-29 16:10","pubTimestamp":1714378212,"startTime":"0","endTime":"0","summary":"智通财经APP讯，仁和药业(000650.SZ)发布2024年第一季度报告，该公司营业收入为12.38亿元，同比减少8.72%。归属于上市公司股东的净利润为1.77亿元，同比减少2.74%。归属于上市公司股东的扣除非经常性损益的净利润为1.01亿元，同比减少42.28%。基本每股收益为0.1266元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1114100.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2430798294","title":"仁和药业(000650.SZ)发布2023年度业绩，净利润5.67亿元，下降1.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2430798294","media":"智通财经网","top":-1,"share":"https://www.laohu8.com/m/news/2430798294?lang=zh_cn&edition=full","pubTime":"2024-04-25 17:28","pubTimestamp":1714037323,"startTime":"0","endTime":"0","summary":"仁和药业(000650.SZ)发布2023年年度报告，报告期内，公司实现营业收入5...","market":"sg","thumbnail":"https://img.zhitongcaijing.com/astock/10.jpg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/astock/10.jpg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1109948.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2430475473","title":"仁和药业最新公告：拟使用合计不超30亿元进行投资理财","url":"https://stock-news.laohu8.com/highlight/detail?id=2430475473","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2430475473?lang=zh_cn&edition=full","pubTime":"2024-04-25 16:51","pubTimestamp":1714035066,"startTime":"0","endTime":"0","summary":"仁和药业公告，公司拟使用合计不超过人民币30亿元额度的自有经营性盈余资金进行投资理财，上述额度内的投资理财在公司董事会、股东会审议通过之日起12个月内有效并授权公司管理层负责具体实施相关事宜。以上内容由证券之星根据公开信息整理，由算法生成（网信算备310104345710301240019号），与本站立场无关，如数据存在问题请联系我们。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042500033741.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2430473428","title":"仁和药业最新公告：2023年净利润5.67亿元 同比下降1.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2430473428","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2430473428?lang=zh_cn&edition=full","pubTime":"2024-04-25 16:50","pubTimestamp":1714035047,"startTime":"0","endTime":"0","summary":"仁和药业发布年报，2023年实现营业收入50.32亿元，同比下降2.35%；净利润5.67亿元，同比下降1.25%。公司拟每10股派发红利2元（含税）。以上内容由证券之星根据公开信息整理，由算法生成（网信算备310104345710301240019号），与本站立场无关，如数据存在问题请联系我们。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042500033737.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2429819645","title":"仁和药业：截止2024年4月19日，大约10万户左右","url":"https://stock-news.laohu8.com/highlight/detail?id=2429819645","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2429819645?lang=zh_cn&edition=full","pubTime":"2024-04-23 20:01","pubTimestamp":1713873683,"startTime":"0","endTime":"0","summary":"证券之星消息，仁和药业(000650)04月23日在投资者关系平台上答复投资者关心的问题。投资者：现在股东人数有多少户？仁和药业董秘：谢谢您的关注！截止2024年4月19日，大约10万户左右。具体数据，根据相关法规，请您先向公司证券部提交股东身份证明，谢谢！以上内容由证券之星根据公开信息整理，由算法生成（网信算备310104345710301240019号），与本站立场无关，如数据存在问题请联系我们。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042300038698.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2416159942","title":"仁和药业(000650.SZ)子公司获玻璃酸纳滴眼液药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2416159942","media":"智通财经网","top":-1,"share":"https://www.laohu8.com/m/news/2416159942?lang=zh_cn&edition=full","pubTime":"2024-03-04 11:44","pubTimestamp":1709523840,"startTime":"0","endTime":"0","summary":"仁和药业(000650.SZ)发布公告，公司子公司江西闪亮制药有限公司近日收到国家药品监督管理局核准签发的关于玻璃酸纳滴眼液《药品注册证书》。据悉，该药品是以玻璃酸钠为主要成分的滴眼液，临床适应症为：用于干眼症，缓解干眼症状。目前，国内已有多家玻璃酸钠滴眼液上市。\n\n股市回暖，抄底炒股先开户！智能定投、条件单、个股雷达……送给你>>\n\n\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-03-04/doc-inamcrfu8126424.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-03-04/doc-inamcrfu8126424.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2400892832","title":"仁和药业(000650.SZ)已耗资6007万元回购股份900万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2400892832","media":"智通财经网","top":-1,"share":"https://www.laohu8.com/m/news/2400892832?lang=zh_cn&edition=full","pubTime":"2024-01-02 16:07","pubTimestamp":1704182820,"startTime":"0","endTime":"0","summary":"仁和药业(000650.SZ)发布公告，截至2023年12月31日，公司通过股份回购专用证券账户以集中竞价交易方式已累计回购公司股份900万股，占公司目前总股本的0.6429%，回购的最高成交价为6.78元/股，最低成交价为6.40元/股，支付的总金额为6007万元。\n\n股市回暖，抄底炒股先开户！智能定投、条件单、个股雷达……送给你>>\n\n\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-01-02/doc-inaacqst8898586.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-01-02/doc-inaacqst8898586.shtml","is_publish_highlight":false,"gpt_icon":0}],"profile":{"ret":0,"listingDate":"1996-12-10","address":"江西省宜春市樟树市葛玄路6号","stockEarnings":[{"period":"1week","weight":-0.0254},{"period":"1month","weight":-0.0061},{"period":"3month","weight":0.1396},{"period":"6month","weight":-0.0467},{"period":"1year","weight":0.0225},{"period":"ytd","weight":-0.0151}],"companyName":"仁和药业股份有限公司","boardCode":"AI0027","perCapita":"13313股","boardName":"医药制造业","registeredCapital":"139993万元","compareEarnings":[{"period":"1week","weight":0.0274},{"period":"1month","weight":0.0209},{"period":"3month","weight":0.1134},{"period":"6month","weight":0.0317},{"period":"1year","weight":-0.0657},{"period":"ytd","weight":0.0437}],"survey":"　　仁和药业股份有限公司主营业务是生产、销售中西药、原料药及健康相关产品。公司主营产品为口服固体制剂、口服液体制剂、大容量注射剂、小容量注射剂、外用洗剂、搽剂、栓剂、软膏剂等剂型药品等。公司是全国通过GMP认证生产线最多的企业之一。","serverTime":1714992246188,"listedPrice":6.26,"stockholders":"100000人(较上一季度减少2.47%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"仁和药业(000650)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供仁和药业(000650)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"仁和药业,000650,仁和药业股票,仁和药业股票老虎,仁和药业股票老虎国际,仁和药业行情,仁和药业股票行情,仁和药业股价,仁和药业股市,仁和药业股票价格,仁和药业股票交易,仁和药业股票购买,仁和药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"仁和药业(000650)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供仁和药业(000650)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}